A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus

BACKGROUND: Severe and refractory immune thrombocytopenia (ITP) affects the life expectancy of patients with systemic lupus erythematosus (SLE) and poses a challenge in their clinical management. This intervention study employed a small sample size to evaluate the efficacy and safety of a modified l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuo, Jiang, Nan, Wang, Li, Zhang, Li, Chen, Hua, Li, Mengtao, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512260/
https://www.ncbi.nlm.nih.gov/pubmed/34729154
http://dx.doi.org/10.1177/20406223211048643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512260/
https://www.ncbi.nlm.nih.gov/pubmed/34729154
http://dx.doi.org/10.1177/20406223211048643

Ejemplares similares